New hope for bile duct cancer: two drug combos tested in trial
NCT ID NCT03044587
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 35 times
Summary
This study tested two different drug combinations in 93 people with advanced bile duct cancer that could not be removed by surgery. The goal was to see how long the cancer could be kept from growing. The trial compared a newer drug combo (nal-IRI with 5-FU and leucovorin) against a standard one (gemcitabine plus cisplatin). Results help guide future treatment choices for this hard-to-treat cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.